drugset / Trial / NCT00531622
An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main purpose of this study is to evaluate the efficacy of saredutant 100mg once daily in combination with escitalopram 10mg once daily compared to saredutant placebo in combination with escitalopram 10mg once daily in patients with major depressive disorder. This study also includes a double-placebo group (saredutant placebo in combination with escitalopram placebo).
Timeline
- Start
- 2007-09
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Saredutant | Small molecule | 100 mg | Oral |
| Background | Escitalopram | Small molecule | 10 mg | Oral |